Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F24157)

Formulation Name

Ubrogepant 50 mg tablet

Company

Allergan

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ubrogepant	DM749I3	Migraine	8A80	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	E00625	Not Available	Disintegrant
Cellulose microcrystalline	E00698	Not Available	Adsorbent; Suspending agent; Diluent
Hydrophobic colloidal silica	E00285	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Mannitol	E00103	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Sodium chloride	E00077	5234	Diluent; Tonicity agent
Sodium stearyl fumarate	E00545	23665634	lubricant
Tocophersolan	E00679	Not Available	Antioxidant; Binding agent; Emulsifying agent; Ointment base; Solubilizing agent; Surfactant; Suspending agent

--------------------